company background image
1332

Touyun Biotech Group SEHK:1332 Stock Report

Last Price

HK$0.45

Market Cap

HK$1.2b

7D

11.3%

1Y

-70.5%

Updated

27 Nov, 2022

Data

Company Financials
1332 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

1332 Stock Overview

Touyun Biotech Group Limited, an investment holding company, designs, develops, manufactures, and sells packaging products in Hong Kong, the People’s Republic of China, Europe, North and South America, and internationally.

Touyun Biotech Group Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Touyun Biotech Group
Historical stock prices
Current Share PriceHK$0.45
52 Week HighHK$1.69
52 Week LowHK$0.36
Beta-0.90
1 Month Change-17.59%
3 Month Change-46.39%
1 Year Change-70.53%
3 Year Change89.36%
5 Year Change-68.21%
Change since IPO95.86%

Recent News & Updates

Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Sep 13
Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt

May 18
Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt

Recent updates

Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Sep 13
Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt

May 18
Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt

Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Dec 24
Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Could The China Touyun Tech Group Limited (HKG:1332) Ownership Structure Tell Us Something Useful?

Mar 12
Could The China Touyun Tech Group Limited (HKG:1332) Ownership Structure Tell Us Something Useful?

If You Had Bought China Touyun Tech Group (HKG:1332) Shares A Year Ago You'd Have Earned 380% Returns

Jan 15
If You Had Bought China Touyun Tech Group (HKG:1332) Shares A Year Ago You'd Have Earned 380% Returns

The Executive Chairman of China Touyun Tech Group Limited (HKG:1332), Liang Wang, Just Bought 8.8% More Shares

Jan 15
The Executive Chairman of China Touyun Tech Group Limited (HKG:1332), Liang Wang, Just Bought 8.8% More Shares

How Much Of China Touyun Tech Group Limited (HKG:1332) Do Insiders Own?

Dec 11
How Much Of China Touyun Tech Group Limited (HKG:1332) Do Insiders Own?

Shareholder Returns

1332HK PackagingHK Market
7D11.3%3.5%-0.2%
1Y-70.5%-30.2%-24.6%

Return vs Industry: 1332 underperformed the Hong Kong Packaging industry which returned -30.2% over the past year.

Return vs Market: 1332 underperformed the Hong Kong Market which returned -24.6% over the past year.

Price Volatility

Is 1332's price volatile compared to industry and market?
1332 volatility
1332 Average Weekly Movement12.8%
Packaging Industry Average Movement6.9%
Market Average Movement8.0%
10% most volatile stocks in HK Market15.0%
10% least volatile stocks in HK Market3.9%

Stable Share Price: 1332 is more volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 13% a week.

Volatility Over Time: 1332's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
1989572Amy Hahttps://touyunbiotech.com.hk

Touyun Biotech Group Limited, an investment holding company, designs, develops, manufactures, and sells packaging products in Hong Kong, the People’s Republic of China, Europe, North and South America, and internationally. It operates through four segments: QR Code Business, Packaging Products, Treasury Investment, and Chlamydomonas Reinhardtii Product Business. The QR Code Business segment provides QR codes on product packaging and solutions, and advertising display services.

Touyun Biotech Group Limited Fundamentals Summary

How do Touyun Biotech Group's earnings and revenue compare to its market cap?
1332 fundamental statistics
Market CapHK$1.25b
Earnings (TTM)-HK$99.64m
Revenue (TTM)HK$313.04m

4.0x

P/S Ratio

-12.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
1332 income statement (TTM)
RevenueHK$313.04m
Cost of RevenueHK$199.40m
Gross ProfitHK$113.64m
Other ExpensesHK$213.28m
Earnings-HK$99.64m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.036
Gross Margin36.30%
Net Profit Margin-31.83%
Debt/Equity Ratio107.3%

How did 1332 perform over the long term?

See historical performance and comparison